VTGN
VistaGen Therapeutics Inc
NASDAQ: VTGN · HEALTHCARE · BIOTECHNOLOGY
$0.61
+2.94% today
Updated 2026-04-30
Market cap
$23.64M
P/E ratio
—
P/S ratio
29.96x
EPS (TTM)
$-1.90
Dividend yield
—
52W range
$0 – $5
Volume
0.7M
VistaGen Therapeutics Inc (VTGN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+11.7%
Last 4 quarters
Revenue YoY growth
+29.5%
Most recent quarter
EPS YoY growth
+2.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-5.1%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-6.6%
2025-11-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-13 | $-0.45 | +7.2% | $0.55 | $0.53 | -3.6% |
| 2025-11-13 | $-0.54 | -1.9% | $4.07 | $3.80 | -6.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.49 | $-0.45 | +7.2% | $303000.00 | +29.5% |
| 2025-09-30 | $-0.53 | $-0.54 | -1.9% | $258000.00 | +41.0% |
| 2025-06-30 | $-0.44 | $-0.47 | -6.8% | $244000.00 | +190.5% |
| 2025-03-31 | $-0.85 | $-0.44 | +48.2% | $-15000.00 | -107.6% |
| 2024-12-31 | $-0.52 | $-0.46 | +11.5% | $234000.00 | -43.1% |
| 2024-09-30 | $-0.39 | $-0.42 | -7.7% | $183000.00 | -34.2% |
| 2024-06-30 | $-0.40 | $-0.35 | +12.5% | $84000.00 | -52.5% |
| 2024-03-31 | $-0.36 | $-0.25 | +30.6% | $197300.00 | +12.4% |
| 2023-12-31 | $-0.30 | $-0.22 | +26.7% | $411400.00 | — |
| 2023-09-30 | $-0.68 | $-0.66 | +2.9% | $278000.00 | — |
| 2023-06-30 | $-0.04 | $-0.94 | -2273.7% | $177000.00 | — |
| 2023-03-31 | $-1.50 | $-1.75 | -16.7% | $175600.00 | — |
Frequently asked questions
Has VistaGen Therapeutics Inc beaten earnings estimates?
VistaGen Therapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +11.7% over the last 4 quarters.
How does VTGN stock react to earnings?
VTGN stock has moved an average of -5.1% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is VistaGen Therapeutics Inc's revenue growth rate?
VistaGen Therapeutics Inc reported year-over-year revenue growth of +29.5% in its most recent quarter, with EPS growing +2.2% year-over-year.